Page last updated: 2024-10-28

fasudil and Axonotmesis

fasudil has been researched along with Axonotmesis in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Madura, T1
Kubo, T1
Tanag, M1
Matsuda, K1
Tomita, K1
Yano, K1
Hosokawa, K1

Other Studies

1 other study available for fasudil and Axonotmesis

ArticleYear
The Rho-associated kinase inhibitor fasudil hydrochloride enhances neural regeneration after axotomy in the peripheral nervous system.
    Plastic and reconstructive surgery, 2007, Volume: 119, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Axotomy; Disease Models, Animal; Male; Nerve

2007